Nutex Health (NASDAQ:NUTX) Trading Down 6.9% – Here’s Why

Nutex Health Inc. (NASDAQ:NUTX) shares dropped 6.9% during trading on Friday . The company traded as low as $152.77 and last traded at $152.9210. 96,309 shares were traded during trading, a decline of 34% from the average daily volume of 145,237 shares. The stock had previously closed at $164.21.

Analyst Ratings Changes

Several equities analysts have recently weighed in on NUTX shares. Wall Street Zen upgraded shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 28th. Weiss Ratings reiterated a “hold (c)” rating on shares of Nutex Health in a research report on Monday, December 29th. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Nutex Health Stock Performance

The business’s 50-day moving average is $152.00 and its 200-day moving average is $119.88. The company has a market capitalization of $1.11 billion, a PE ratio of 8.61 and a beta of -0.08. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.18 and a current ratio of 3.20.

Nutex Health (NASDAQ:NUTX) last announced its earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share (EPS) for the quarter, beating the consensus estimate of ($5.43) by $13.19. Nutex Health had a net margin of 11.62% and a return on equity of 37.44%. The company had revenue of $243.99 million during the quarter, compared to analyst estimates of $221.93 million.

Insider Activity

In other Nutex Health news, CFO Jon Christian Bates purchased 750 shares of the firm’s stock in a transaction dated Tuesday, November 25th. The shares were acquired at an average price of $136.71 per share, with a total value of $102,532.50. Following the purchase, the chief financial officer directly owned 5,638 shares in the company, valued at approximately $770,770.98. This trade represents a 15.34% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 36.92% of the stock is owned by company insiders.

Hedge Funds Weigh In On Nutex Health

Hedge funds have recently bought and sold shares of the stock. State of Alaska Department of Revenue purchased a new stake in shares of Nutex Health in the third quarter worth approximately $30,000. BNP Paribas Financial Markets boosted its stake in shares of Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after purchasing an additional 290 shares in the last quarter. Ameritas Investment Partners Inc. bought a new stake in shares of Nutex Health in the 2nd quarter worth about $44,000. Police & Firemen s Retirement System of New Jersey bought a new position in shares of Nutex Health in the second quarter valued at approximately $97,000. Finally, KLP Kapitalforvaltning AS acquired a new stake in Nutex Health during the 2nd quarter worth $112,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.